SCHIANO MORIELLO, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 261
AS - Asia 195
EU - Europa 163
SA - Sud America 12
AF - Africa 6
Totale 637
Nazione #
US - Stati Uniti d'America 254
SG - Singapore 114
IT - Italia 85
HK - Hong Kong 68
NL - Olanda 22
RU - Federazione Russa 22
DE - Germania 14
BR - Brasile 10
CN - Cina 6
FI - Finlandia 6
GB - Regno Unito 6
CA - Canada 5
CI - Costa d'Avorio 5
IN - India 4
FR - Francia 3
CH - Svizzera 2
IE - Irlanda 2
AT - Austria 1
AZ - Azerbaigian 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
MX - Messico 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
Totale 637
Città #
Hong Kong 68
Singapore 55
Ashburn 46
Santa Clara 37
Naples 27
Chandler 23
Amsterdam 19
Rome 17
Bologna 6
Helsinki 5
Seattle 5
Council Bluffs 4
Lawrence 4
Millbury 4
Nuremberg 4
Boston 3
Catania 3
London 3
Los Angeles 3
Washington 3
Bern 2
Des Moines 2
Dublin 2
Fairfield 2
Formia 2
Frankfurt am Main 2
Hyderabad 2
Kronberg 2
Milan 2
Ottawa 2
Paris 2
Prato 2
São Paulo 2
Toronto 2
Afragola 1
Alcamo 1
Alto Alegre do Maranhão 1
Baku 1
Bayreuth 1
Belo Horizonte 1
Boardman 1
Cairo 1
Cardito 1
Chengdu 1
Cigliano 1
Crispano 1
Dallas 1
Falkenstein 1
Fisciano 1
Genoa 1
Itajaí 1
Krefeld 1
Lappeenranta 1
Liberty Lake 1
Manila 1
Marseille 1
Mexico City 1
Monteforte Irpino 1
Montreal 1
Moscow 1
Newark 1
Norwalk 1
Oriximiná Municipality 1
Palermo 1
Panama City 1
Perugia 1
Phoenix 1
Pontelandolfo 1
Quito 1
Recife 1
Rio de Janeiro 1
Savoca 1
São José dos Pinhais 1
The Dalles 1
Turvo 1
Yongzhou 1
Totale 409
Nome #
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 50
Risk of professional accidental exposure to biological agents in health care workers: a retrospective analysis carried out in a southern Italian tertiary hospital 49
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 46
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 43
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 37
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 37
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 35
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 31
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 30
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 28
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 27
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 26
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 26
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 19
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 17
Update on the Management of Surgical Site Infections 17
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 17
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 16
Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study 14
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 14
Measles in pregnant women: A systematic review of clinical outcomes and a meta-analysis of antibodies seroprevalence 13
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused 13
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 13
Re: Persistent COVID-19 in immunocompromised patients-Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al 13
Pharmacological approaches to prevent vertical transmission of HIV and HBV 12
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 8
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical Clustering 8
Personalized care approaches to hepatitis C therapy: recent advances and future directions 6
COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination 5
The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel 4
Totale 674
Categoria #
all - tutte 4.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/20218 0 0 0 1 0 0 1 0 3 3 0 0
2021/202222 1 0 0 0 0 0 0 0 1 2 9 9
2022/2023119 4 7 3 5 16 16 14 13 15 18 7 1
2023/2024136 3 18 20 14 18 21 3 8 13 2 11 5
2024/2025383 22 5 4 19 41 68 106 62 56 0 0 0
Totale 674